Brown Advisory’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
VCM
6CM
KGAMU
WPM
RC
QOP
Brown Advisory's CDLX Position: Q1 2026 in Review
Brown Advisory reduced its Cardlytics (CDLX) stake by 3.5% in Q1 2026, selling an estimated $3.68K and leaving 10,383 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #1362.
Brown Advisory first reported a position in CDLX in Q4 2020 and has held it in 21 quarters since. The position peaked at $3.52M in Q1 2024. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.
- Brown Advisory held 10,383 shares of Cardlytics worth $109K as of Q1 2026.
- Brown Advisory sold 377 Cardlytics shares in Q1 2026, an estimated $3.68K.
- Cardlytics made up ﹤0.01% of Brown Advisory's portfolio in Q1 2026, its #1362 holding.
- Brown Advisory first reported a position in Cardlytics in Q4 2020 and has held it in 21 quarters since.
- Brown Advisory's Cardlytics position peaked at $3.52M in Q1 2024.
- 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.
Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.